Naar het menu

MMR vaccination and autism: no indication for an association

Status

Published
25 January 2007

Keywords

Download publications

In the Netherlands, all children above the age of 14 months are vaccinated against mumps, measles and rubella (or German measles). This is the so-called MMR vaccination. This approach prevents numerous cases of these diseases in children every year. There is widespread acceptance of this inoculation.

Committee

  • Prof. A.C.B. Peters, Professor of Paediatric Neurology; University Medical Centre, Utrecht, chairperson
  • A. Ambler, Inspectie voor de gezondheids­zorg (Dutch Health Inspectorate), advisor till 1 December 2005
  • Dr S.G. van Duinen, Neuropathologist; Leiden University Medical Center
  • Dr E.J.P. Lommen, Paedriatrician; Waalre
  • Dr R.H.B. Meyboom, Physician; Stichting Landelijke Registratie Evaluatie Bijwerkingen (Foundation for National Registration and Evaluation of Side effects), Den Bosch; Uppsala monitoring centre, Uppsala, Sweden
  • Dr H.C. Rümke, Director of Clinical Research, Vaxinostics; Vaccine Centre of Erasmus University Rotterdam
  • Dr H.P. Verbrugge, Paedriatrician; Santpoort
  • P.E. Vermeer-de Bondt, Public Health Physician; National Institute for Public Health and the Environment (RIVM), Bilthoven, advisor
  • Dr P.M.E. Wertheim-van Dillen, Clinical virologist; Nigtevecht
  • Dr K. Groeneveld, Health Council of the Netherands, The Hague, scientific secretary

Download publications

Health Council of the Netherlands. MMR vaccination and autism: no indication for an association. The Hague: Health Council of the Netherlands, 2007; publication no. 2007/04E. ISBN  978-90-5549-837-6

Newsflash